Neonatology Practice Questions

Q: The most common congenital anomaly in a baby born to an IDDM mother is:

Cardiovascular anomalies. ***Cardiovascular anomalies*** - **Ventricular septal defects (VSDs)**, atrial septal defects (ASDs), and **transposition of the great arteries** are among the most common congenital heart defects seen in infants of diabetic mothers. - Maternal diabetes, especially poor glycemic control during early pregnancy, significantly increases the risk of these cardiac malformations due to its impact on **cardiogenesis**. *Neural tube defect* - While **neural tube defects** (NTDs) like anencephaly and spina bifida are increased in infants of diabetic mothers, they are not the most common type of anomaly. - The risk of NTDs is higher with **poor glycemic control** during the first trimester. *G.I.T anomalies* - **Gastrointestinal anomalies**, such as **anorectal atresia** or **duodenal atresia**, are also associated with maternal diabetes. - However, their incidence is lower compared to cardiovascular anomalies in this population. *Pulmonary anomalies* - **Pulmonary anomalies** are less common as major congenital malformations directly linked to maternal diabetes. - The primary pulmonary issue in infants of diabetic mothers is often related to **delayed lung maturity** (respiratory distress syndrome), rather than structural defects.

Q: The following is not a feature of Pierre-Robin syndrome.

Coloboma Iris. **Coloboma Iris** - **Coloboma iris** is a congenital anomaly where part of the iris is missing, often associated with a different set of genetic conditions like **CHARGE syndrome**, not typically seen in Pierre-Robin syndrome. - The classic triad of Pierre-Robin syndrome consists of **micrognathia**, **glossoptosis**, and **cleft palate**, none of which directly involve ocular malformations like coloboma. *Hearing defect* - **Hearing defects** can be an associated feature in Pierre-Robin syndrome, often secondary to recurrent **otitis media** due to the structural abnormalities of the palate and Eustachian tube dysfunction. - Chronic middle ear infections can lead to **conductive hearing loss** in affected individuals. *Respiratory distress* - **Respiratory distress** is a common and serious feature of Pierre-Robin syndrome, caused by **glossoptosis** (posterior displacement of the tongue) which obstructs the airway. - This can lead to significant breathing problems, especially during feeding and sleep, sometimes requiring intervention such as positioning or tracheostomy. *Mandibular hypoplasia* - **Mandibular hypoplasia**, or a small lower jaw (**micrognathia**), is a defining characteristic of Pierre-Robin syndrome and is the primary factor leading to the other features. - The underdeveloped mandible prevents the tongue from descending during fetal development, leading to **glossoptosis** and often a **cleft palate**.

Q: A neonate has no respiratory efforts, no response or reflex to stimulation, a heart rate less than 100, blue extremities, and poor muscle tone. What is the total APGAR score?

2. ***Correct: 2*** - The APGAR score is calculated by evaluating five components, each scored 0-2 points: - **Appearance (color):** Blue extremities with pink body = **1 point** - **Pulse (heart rate):** <100 bpm = **1 point** - **Grimace (reflex irritability):** No response to stimulation = **0 points** - **Activity (muscle tone):** Poor/flaccid tone = **0 points** - **Respiration:** No respiratory effort = **0 points** - **Total score: 1 + 1 + 0 + 0 + 0 = 2 points** - This indicates a severely depressed neonate requiring immediate resuscitation *Incorrect: 1* - A score of 1 would indicate only one parameter scoring 1 point - In this scenario, **two parameters** (heart rate and color) each score 1 point - The clinical findings described yield a total of 2 points, not 1 *Incorrect: 3* - A score of 3 would require an additional point from any category - This could occur with some grimace response (1 point) or some flexion of extremities (1 point) - The described neonate has **no reflex response** and **poor muscle tone**, so neither category contributes points beyond what's already counted *Incorrect: 4* - A score of 4 would indicate better overall status with additional positive findings - This might include moderate respiratory effort (1 point), good grimace (1-2 points), or better muscle tone (1-2 points) - The clinical presentation described is much more severe, with complete absence of respiratory effort and reflex responses

Q: All of the following are true about "secondary apnea" in a neonate except:

Baby may respond to tactile stimulation. ***Baby may respond to tactile stimulation*** - In **secondary apnea**, the neonate is typically in a state of **cardiovascular depression** and will not respond to simple tactile stimulation. - Active resuscitation with **positive pressure ventilation** is usually required to reverse secondary apnea. *The baby is not breathing* - This is true because **apnea** by definition means the temporary cessation of breathing, and in this phase, respirations have ceased. - Absence of breathing is the key characteristic of both primary and secondary apnea. *HR may become < 100/min* - This is true, as **secondary apnea** is associated with **profound bradycardia** and a significant decline in heart rate, often below 100 bpm. - The drop in heart rate indicates worsening **hypoxia** and **acidosis**. *It may be present even at birth* - This is true, as a neonate can enter secondary apnea if they experience significant **hypoxia** and stress **in utero** or during the birth process. - Factors like placental insufficiency, cord compression, or difficult delivery can lead to this state at the moment of birth.

Q: Cephalhematoma usually disappears within what timeframe?

6–8 weeks. ***6–8 weeks*** - A **cephalhematoma** is a collection of blood under the periosteum of a neonate's skull bone, typically resolving within **6–8 weeks** as the blood is slowly reabsorbed. - This timeframe represents the most commonly cited resolution period in standard pediatric references for uncomplicated cephalhematomas. - Complete resolution may occasionally extend to **2-3 months** in larger hematomas, but most resolve by 8 weeks. *5–7 weeks* - While some cephalhematomas may begin to resolve by this timeframe, **6–8 weeks** is more consistently reported in pediatric literature as the typical complete resolution period. - This slightly shorter timeframe doesn't account for the slower reabsorption rate seen in many cases, particularly with larger hematomas. *2–4 weeks* - **Cephalhematomas** rarely resolve this quickly, as the subperiosteal location and the slow rate of blood reabsorption usually require a longer period. - Resolution within this short timeframe is more characteristic of **caput succedaneum**, which involves superficial edema rather than subperiosteal blood collection and resolves within days. *4–6 months* - This timeframe is generally too long for the resolution of a typical **cephalhematoma** and would suggest potential complications. - Such prolonged persistence could indicate **calcification** of the hematoma or a very large collection requiring extended reabsorption time, which is uncommon.

Q: What is the appropriate treatment for a neonate with nasal congestion?

Normal saline nose drops. ***Normal saline nose drops*** - **Normal saline nose drops** help to thin nasal secretions and moisturize the nasal passages, making it easier for the neonate to breathe. - This is a **safe and effective** first-line treatment for nasal congestion in neonates, as it avoids systemic side effects. *Oral antihistamines* - Oral antihistamines are generally **not recommended** for neonates due to potential side effects like drowsiness, irritability, and respiratory depression. - They are also not very effective for clearing thick nasal secretions, which is often the cause of congestion in infants. *Oral antibiotics* - Nasal congestion in neonates is typically **viral** in origin or due to environmental factors, making antibiotics ineffective and unnecessary. - **Overuse of antibiotics** can lead to antibiotic resistance and disrupt the infant's normal gut flora. *Parenteral antibiotics* - Parenteral antibiotics are reserved for **severe bacterial infections** and are an inappropriate treatment for uncomplicated nasal congestion. - They carry risks such as pain, infection at the injection site, and systemic side effects, which are not justified for mild symptoms.

Q: What is the next step in managing a 3-day-old neonate with a bilirubin level of 18 mg/dL?

Start phototherapy and continue breastfeeding. ***Start phototherapy and continue breastfeeding*** - A bilirubin level of **18 mg/dL** in a 3-day-old neonate exceeds the threshold for high-intermediate risk zone on the **Bhutani nomogram**, thus requiring **phototherapy** to prevent severe hyperbilirubinemia and **kernicterus**. - **Breastfeeding** should be continued as it is crucial for hydration and nutrition, and interruption is usually not indicated unless there is a specific and confirmed diagnosis of **breast milk jaundice** with extremely high bilirubin levels. - **Monitoring** for response to phototherapy and further intervention if bilirubin continues to rise is essential. *Stop breastfeeding* - Stopping breastfeeding is a measure reserved for specific and severe cases of **breast milk jaundice**, where the bilirubin levels are very high and unresponsive to phototherapy, which is not indicated here. - Interruption of breastfeeding often leads to **dehydration**, which can worsen hyperbilirubinemia, and may discourage successful long-term breastfeeding. *Start phototherapy and stop breastfeeding* - While **phototherapy** is indicated, stopping breastfeeding is generally not recommended unless there's a strong indication of **breast milk jaundice** needing a trial of formula feeding, which is not the typical first step. - This approach combines a necessary intervention with an often counterproductive one, as adequate fluid intake through breastfeeding helps **bilirubin excretion**. *Exchange transfusion* - **Exchange transfusion** is considered for neonates with very high bilirubin levels (typically **>25 mg/dL** in this age group, or if there are signs of **acute bilirubin encephalopathy**) that are unresponsive to intensive phototherapy. - A bilirubin level of **18 mg/dL** in an otherwise healthy 3-day-old is below the typical threshold for immediate exchange transfusion and would usually warrant phototherapy initially.

Q: A newborn whose weight is less than 1500 grams is termed as

Very low birth weight. ***Very low birth weight*** - A newborn with a birth weight **less than 1500 grams** is classified as very low birth weight (VLBW). - This category is associated with increased risks of morbidity and mortality for the infant. - VLBW includes all infants weighing <1500g, encompassing both those between 1000-1499g and those <1000g. *Low birth weight* - This classification applies to infants born weighing **less than 2500 grams**, which is a broader category. - It includes VLBW infants as well as those weighing between 1500-2499 grams. *Not a recognized classification* - This is incorrect as <1500g is a well-established and recognized classification. - Birth weight classifications are critical for assessing neonatal risks and guiding clinical management. *Extremely low birth weight* - This term is reserved for infants born weighing **less than 1000 grams**. - ELBW is a subset of VLBW, representing the highest-risk group. - Infants in this category face the highest risks of severe health complications and long-term developmental issues.

Q: Which of the following is the preferred treatment after birth for a baby of an HBsAg-positive mother?

HepB immunoglobulin + HepB immunization. ***HepB immunoglobulin + HepB immunization*** - This combination provides both **passive immunity** (immunoglobulin) and **active immunity** (immunization) to the newborn. - Administration within **12 hours of birth** is crucial to prevent perinatal transmission of hepatitis B from an HBsAg-positive mother. *HepB immunoglobulin only* - Provides only **temporary passive immunity** and does not induce long-lasting protection against hepatitis B. - While it offers immediate protection, it eventually wanes, leaving the infant susceptible without active immunization. *Only HepB immunization* - Induces **active immunity**, but it takes time to develop, leaving a window of vulnerability postpartum. - It would not provide immediate protection against the high risk of transmission from an HBsAg-positive mother. *No active treatment required* - This approach is incorrect and dangerous as infants of HBsAg-positive mothers are at a **very high risk of acquiring chronic hepatitis B infection**. - Without intervention, there is a **70-90% chance of developing chronic hepatitis B**, which can lead to serious liver disease later in life.

Question 1

Which of the following statements about the differences between neonates and adults is true?

Accepted Answer

Their excretory ability of the kidney is less well developed.

Answer

They can tolerate large doses of certain drugs on body weight basis.

Answer

Their gastric emptying is prolonged.

Answer

Their hepatic metabolizing enzyme activity is slower.

Question 2

The most common congenital anomaly in a baby born to an IDDM mother is:

Accepted Answer

Cardiovascular anomalies

Answer

Neural tube defect

Answer

G.I.T anomalies

Answer

Pulmonary anomalies

Question 3

The following is not a feature of Pierre-Robin syndrome.

Accepted Answer

Coloboma Iris

Answer

Respiratory distress

Answer

Mandibular hypoplasia

Answer

Hearing defect

Question 4

A neonate has no respiratory efforts, no response or reflex to stimulation, a heart rate less than 100, blue extremities, and poor muscle tone. What is the total APGAR score?

Accepted Answer

2

Answer

1

Answer

3

Answer

4

Question 5

All of the following are true about "secondary apnea" in a neonate except:

Accepted Answer

Baby may respond to tactile stimulation

Answer

HR may become < 100/min

Answer

It may be present even at birth

Answer

The baby is not breathing

Question 6

Cephalhematoma usually disappears within what timeframe?

Accepted Answer

6–8 weeks

Answer

4–6 months

Answer

2–4 weeks

Answer

5–7 weeks

Question 7

What is the appropriate treatment for a neonate with nasal congestion?

Accepted Answer

Normal saline nose drops

Answer

Oral antibiotics

Answer

Oral antihistamines

Answer

Parenteral antibiotics

Question 8

What is the next step in managing a 3-day-old neonate with a bilirubin level of 18 mg/dL?

Accepted Answer

Start phototherapy and continue breastfeeding

Answer

Stop breastfeeding

Answer

Start phototherapy and stop breastfeeding

Answer

Exchange transfusion

Question 9

A newborn whose weight is less than 1500 grams is termed as

Accepted Answer

Very low birth weight

Answer

Low birth weight

Answer

Not a recognized classification

Answer

Extremely low birth weight

Question 10

Which of the following is the preferred treatment after birth for a baby of an HBsAg-positive mother?

Accepted Answer

HepB immunoglobulin + HepB immunization

Answer

HepB immunoglobulin only

Answer

Only HepB immunization

Answer

No active treatment required

Neonatology — MCQs

Neonatology — MCQs

On this page

Practice by Chapter

Want unlimited practice?